Related Experiment Videos
[Soft tissue sarcomas in childhood (author's transl)]
Langenbecks Archiv Fur Chirurgie
|January 1, 1982
Summary
Combined tumor therapy significantly improved survival rates for soft tissue sarcomas in children and adults. This multimodal approach, including surgery, radiation, and chemotherapy, offers new hope for patients with these rare cancers.
Area of Science:
- Oncology
- Pediatric Oncology
- Surgical Oncology
Context:
- Soft tissue sarcomas represent a significant portion of childhood solid tumors.
- A retrospective analysis of 477 patients treated between 1950 and 1980.
- Pediatric cases included high proportions of rhabdomyosarcoma and angioblastic sarcoma.
Purpose:
- To evaluate the efficacy of combined tumor therapy for soft tissue sarcomas.
- To analyze survival rates before and after the introduction of multimodal treatment.
- To characterize the prevalence and types of soft tissue sarcomas in a pediatric cohort.
Summary:
- 477 patients with soft tissue sarcomas were analyzed, with 18.2% being children.
- Soft tissue sarcomas constituted 22.8% of childhood solid tumors (excluding brain tumors).
- Combined tumor therapy (surgery, radiation, chemotherapy) dramatically increased survival from 29% to 58%.
Impact:
- Demonstrates the substantial benefit of multimodal treatment in improving soft tissue sarcoma outcomes.
- Highlights the importance of combined modality treatment in pediatric oncology.
- Provides historical data on soft tissue sarcoma treatment effectiveness.